A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

ABSTRACT:

SUBMITTER: Lee HC 

PROVIDER: S-EPMC6773683 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature